Sign in
Companies / ABBV vs VTRS

ABBV vs VTRS: AbbVie and Viatris

Pharmaceuticals
Compare more companies

AbbVie (ABBV) reported $61.2B in revenue against a 6.9% net margin, while Viatris (VTRS) reported $14.3B at a -24.6% net margin, most recently.

MetricABBVVTRS
Revenue$61.2B$14.3B
Net Income$4.2B$-3.5B
Gross Margin70.2%35.1%
Operating Margin24.6%-18.6%
EPS (Diluted)$2.36$-3.00
Free Cash Flow$17.8B$1.9B
Total Debt$67.0B$14.4B
P/E Ratio96.8×n/m
P/B Ration/mn/m
Stock Price$288.14$19.00
Free: last 5 years
Fiscal yearFY2018 🔒FY2019 🔒FY2020 🔒FY2021FY2022FY2023FY2024FY2025
ABBV Revenue•••••••••••••••$56.2B$58.1B$54.3B$56.3B$61.2B
VTRS Revenue•••••••••••••••$17.9B$16.3B$15.4B$14.7B$14.3B

More on ABBV

More on VTRS

Other comparisons